Infinium Pharmachem IPO GMP | Details, Date, Price, Review

Infinium Pharmachem IPO Details ( Infinium Pharma IPO Review )

(31 Mar 2023 – 05 Apr 2023)

Infinium Pharmachem Limited: Manufacturer and Supplier of Iodine Derivatives, APIs, and Bulk Drugs via Iodination Reaction since 2003.

The company provides Research and Development (R&D) services, commercial-scale manufacturing, and packaging for the pharmaceutical, agrochemical, nutraceutical, specialty chemicals, and other chemical industries.

Infinium Pharmachem’s manufacturing plant, spanning over a 4100 sq. mtr. plot area, is situated in Gujarat, India. The facility is both FDA certified and GMP compliant, with the capacity to produce intricate iodine derivatives.

With over 200+ iodine derivatives and 7+ APIs, Infinium Pharmachem serves more than 15 countries across the globe.

Infinium Pharmachem Limited Company Product:

• Featured Iodine Derivatives:
  1. Dess Martin Periodinane
  2. Iodobenzene
  3. N-Iodosuceinamide
  4. Lithium Iodide Hydrate
  5. Tetrabutylammonium Iodide
  6. Chloroiodomethane
  7. Tetraethylammonium Iodide
  8. Ethyl Iodide
  9. Hydroiodic Acid
  10. Diiodometheme
  11. Methyl Iodide
  12. Trimethylsulphoxonium Iodide
• Active Pharmaceutical Ingredients (API):
  • Potassium Iodide
  • Sodium Iodide
  • Povidone Iodine
  • Iodoform (USP)

Infinium Pharmachem IPO Competitive Strength

• Expertise of the Company in Research and Development (R&D) (250+ Iodine Derivatives Researched & Developed). Most of our customers’ demands are fulfilled by us which our competitors find challenging to do.
• State of the art latest machinery and processes
• Professional and experience team including our in-house R&D and Quality Assurance departments.
• Strong presence and continuous growth in emerging market business
• Expanding reach to over 15+ countries across the globe while significantly increasing customer base in India too.
• Competitive marketing Strategy garnering consistent growth in revenue.
• Dependable suppliers: The Company has a good quantity of competent raw material suppliers, which allows it to bypass many supply chain bottlenecks.

Infinium Pharmachem IPO Financials Performance ( Results )

Infinium Pharmachem Limited Financial Information ( Restated Consolidated )

All Amount in ₹ Lakhs

Period Ended	Total Assets	Total Revenue	PAT	EPS (₹)	Net Worth	NAV (₹)	Reserves	Borrowing
31-Mar-20	2,244.60	3,941.64	93.40	9.19	424.74	41.78	-13.51	566.17
31-Mar-21	3,418.27	7,115.37	272.48	26.80	702.32	69.08	-14.00	579.47
31-Mar-22	5,899.95	10,005.25	610.64	60.07	1,310.22	128.88	105.77	1,385.01
30-Sep-22	7,075.71	7,985.39	551.01	10.84	1,855.77	36.55	–	1,614.71

Objective of IPO Issue

• Marketing and branding expenses (including registration in reach – Europe, and other marketing expenses)
• Repayment of some of the existing loans and expansion of units
• To meet incremental working capital requirements
• To meet public issue expenses

Infinium Pharmachem IPO Basic Details

IPO Date	Mar 31, 2023 to Apr 5, 2023
Listing Date	Monday, April 17, 2023
Face Value	₹10 per share
Price	₹135 per share
Lot Size	1000 Shares
Issue Size	1,875,000 shares (aggregating up to ₹25.31 Cr)
Fresh Issue	1,875,000 shares (aggregating up to ₹25.31 Cr)
Issue Type	Book Built Issue IPO
Listing At	NSE SME
P/E (x)	2.25
QIB Shares Offered	50% of the Offer
NII (HNI) Shares Offered	15% of the Offer
Retail Shares Offered	35% of the Offer
Company Promoters	Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani And Mr. Mitesh Lavjibhai Chikhaliya

Infinium Pharmachem IPO Timetable

Infinium Pharmachem IPO will open on Mar 31, 2023 and close on Apr 05, 2023. You can join Infinium Pharmachem IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.

Event	Date
Opening Date	Mar 31, 2023
Closing Date	Apr 5, 2023
Basis of Allotment	Apr 11, 2023
Initiation of Refunds	Apr 12, 2023
Credit of Shares to Demat	Apr 13, 2023
Listing Date	Apr 17, 2023

Infinium Pharmachem IPO Lot Size

For retail investors in Infinium Pharmachem IPO, 1000 shares will come in 1 lot or the minimum investment will be ₹135,000. Retail-individual investors can apply for up to 1 lots or the maximum investment will be ₹135,000.

Application	Lots	Shares	Amount
Retail (Min)	1	1000	₹135,000
Retail (Max)	1	1000	₹135,000
S-HNI (Min)	2	2000	₹270,000

Infinium Pharmachem IPO Promoter Holding

Pre Issue Share Holding	100.00%
Post Issue Share Holding	–

Infinium Pharmachem IPO Valuation – FY2022

Earning Per Share (EPS)	₹10.83 per Equity Share
Price/Earning P/E Ratio	–
Return on Net Worth (RoNW)	43.85%
Net Asset Value (NAV)	₹123.45 per Equity Share
Upper Price/Book Value (Price/BV) Ratio	–

Infinium Pharmachem Ltd Peer comparison

Company Name	Result Type	CPM	Face Value	EPS (₹)	P/E Ratio	RoNW (%)	NAV (₹)	P/BV Ratio
Infinium Pharmachem Limited	Standalone	–	10	10.83	–	43.85	123.45	–
Peer Group
Samrat Pharmachem Limited	Standalone	404	10	55.62	12.99	36.70	151.54	2.01

Infinium Pharmachem IPO GMP Live Update, Kostak Rate day by day

Date	GMP	Kostak	Subject to
13 April 2023	₹2	–	–
12 April 2023	₹2.5	–	–
11 April 2023	₹3	–	–
10 April 2023	₹2	–	–
9 April 2023	₹3	–	–
8 April 2023	₹3	–	–
7 April 2023	₹2	–	–
6 April 2023	₹2	–	–
5 April 2023	₹2	–	–
4 April 2023	₹3	–	–
3 April 2023	₹5	–	–
2 April 2023	₹0	–	–
1 April 2023	₹0	–	–
31 March 2023	₹0	–	–
30 March 2023	₹0	–	–
29 March 2023	₹0	–	–
28 March 2023	₹0	–	–
27 March 2023	₹0	–	–
26 March 2023	₹0	–	–
25 March 2023	₹0	–	–

Infinium Pharmachem IPO Detail Video:

Infinium Pharmachem IPO Subscription Status (Bidding Detail)

The Infinium Pharmachem IPO on Apr 5, 2023 at 5:49:00 PM was subscribed 1.84 times, with the retail category being subscribed 1.86 times, the NII (Non-Institutional Investor) category being subscribed 1.80 times.

Category	Subscription
NII	1.80x
Retail	1.86x
Total	1.84x

Infinium Pharmachem IPO Prospectus

Infinium Pharmachem IPO DRHP	Download
Infinium Pharmachem IPO RHP	Download

Infinium Pharmachem IPO Rating

Our Rating

1.0/5.0

Infinium Pharmachem Compnay Contact Information

INFINIUM PHARMACHEM LIMITED

Registered office: 38 G.I.D.C Sojitra, Taluka – Sojitra, Dist. – Anand, Gujarat – 387240, India.
Website: www.infiniumpharmachem.com
Corporate Office: Suite 205, Sigma Prime, 2nd Floor, Nr. Sardar Patel Statue Vallabh Vidhyanagar, Dist. Anand – 388120, Gujarat
E-Mail: cs@infiniumpharmachem.com
Telephone No: +91 (2692) 238849, 238850, 297446
Company Secretary and Compliance Officer: Ms. Vrunda Harishbhai Patel
Company Promoters: Mr. Sanjaykumar Viththalbhai Patel, Mr. Pravin Bhadabhai Madhani
And Mr. Mitesh Lavjibhai Chikhaliya

Infinium Pharmachem IPO Registrar

BIGSHARE SERVICES PRIVATE LIMITED

SEBI Registration Number: INR000001385
Address: Office No. S6 – 2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali
Caves Road, Andheri – [East], Mumbai – 400093, Maharashtra, India.
Tel. Number: +91 22 6263 8200
Fax: +91 22 6263 8299
Email Id: ipo@bigshareonline.com
Investors Grievance Id: investor@bigshareonline.com
Website: www.bigshareonline.com
Contact Person: Mr. Swapnil Kate

Infinium Pharmachem IPO Lead Manager

SWASTIKA INVESTMART LIMITED

SEBI Registration Number: INM000012102
Merchant Banking Division Address: Flat No18 Floor 2 North Wing Madhaveshwar
Coop Hsg Society Ltd Madhav Nagar, 11/12 S V Road Andheri W Mumbai Mumbai City –
400058 (Maharashtra).
Telephone Number: +91-22-26254568-69
Email Id: merchantbanking@swastika.co.in
Investors Grievance Id: investorgreivance@swastika.co.in
Website: www.swastika.co.in
Contact Person: Mr. Mohit R. Goyal
CIN: L65910MH1992PLC067052

Infinium Pharmachem IPO FAQs